4.24
Voyager Therapeutics Inc Azioni (VYGR) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
19.67%
5.20
|
6.473 | 6.278 | 24.63 | 29.58 |
|
1.60%
41.83
|
41.17 | 44.58 | 38.41 | 44.60 |
Benefits Costs and Expenses |
2.96%
38.57
|
37.46 | 40.18 | 33.63 | 39.70 |
Costs And Expenses |
2.96%
38.57
|
37.46 | 40.18 | 33.63 | 39.70 |
Operating Income/Loss |
5.57%
-36.62
|
-34.69 | -38.30 | -13.78 | -15.03 |
Nonoperating Income/Loss |
12.16%
3.258
|
3.709 | 4.396 | 4.779 | 4.908 |
Income/Loss From Continuing Operations Before Tax |
7.69%
-33.37
|
-30.98 | -33.90 | -9.001 | -10.12 |
Income Tax Expense/Benefit |
59.46%
0.015
|
0.037 | 0.584 | 0.043 | 0.024 |
Income/Loss From Continuing Operations After Tax |
7.61%
-33.38
|
-31.02 | -34.49 | -9.044 | -10.14 |
|
7.61%
-33.38
|
-31.02 | -34.49 | -9.044 | -10.14 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.54%
58.67
|
58.35 | 0.1031 | 57.85 | 57.72 |
Diluted Average Shares |
0.54%
58.67
|
58.35 | 0.1031 | 57.85 | 57.72 |
Basic Earnings Per Share |
7.55%
-0.57
|
-0.53 | -0.60 | -0.16 | -0.18 |
Diluted Earnings Per Share |
7.55%
-0.57
|
-0.53 | -0.60 | -0.16 | -0.18 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):